Neuronetics Secures Medi-Cal Coverage for TMS Treatment in California
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that California Medicaid, known as Medi-Cal, will now cover transcranial magnetic stimulation (TMS) for both adults and adolescents aged 15 and older …
Neuronetics Secures Medi-Cal Coverage for TMS Treatment in California Read More